Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:age_group |
12 months to 12 years
|
| gptkbp:approves |
gptkb:1995
|
| gptkbp:availability |
widely available
|
| gptkbp:average_temperature |
-15° C or lower
|
| gptkbp:clinical_trial |
conducted before approval
|
| gptkbp:combination_vaccine |
MMRV vaccine
|
| gptkbp:community_health |
reduced incidence of chickenpox
|
| gptkbp:contraindication |
pregnancy
immunocompromised individuals history of severe allergic reaction to vaccine components |
| gptkbp:developed_by |
gptkb:Merck_&_Co.
|
| gptkbp:dosage_form |
two doses
not routinely recommended |
| gptkbp:herd_immunity_effect |
protects unvaccinated individuals
|
| https://www.w3.org/2000/01/rdf-schema#label |
varicella vaccine
|
| gptkbp:is_effective_against |
about 90% effective
|
| gptkbp:is_recommended_by |
gptkb:CDC
gptkb:WHO |
| gptkbp:is_vulnerable_to |
varies by region
updated periodically varies by country requires refrigeration long-lasting immunity monitored for safety ongoing studies on long-term effects administered by healthcare professionals attenuated live virus part of childhood immunization schedule high effectiveness in preventing severe disease introduced in the US in 1995 significantly reduced hospitalizations studies on vaccine safety continue reduced healthcare costs associated with chickenpox |
| gptkbp:price |
varies by country
|
| gptkbp:route_of_administration |
subcutaneous
|
| gptkbp:side_effect |
fever
rare serious allergic reactions mild rash tenderness at injection site |
| gptkbp:targets |
chickenpox
|
| gptkbp:type |
live attenuated vaccine
|
| gptkbp:vaccine_administration_age |
second dose at 4-6 years
first dose at 12-15 months |
| gptkbp:vaccine_effect |
decreased mortality from chickenpox
|
| gptkbp:vaccine_information |
available from health departments
|
| gptkbp:vaccine_myths |
debunked by health authorities
|
| gptkbp:vaccine_public_health |
important for preventing outbreaks
|
| gptkbp:bfsParent |
gptkb:diphtheria_toxoid
gptkb:AS04_adjuvant_system |
| gptkbp:bfsLayer |
6
|